Success Stories: Premium Processing Accelerates EB2-NIW Approval for a Biotechnology Postdoctoral Associate from India

Client’s Testimonial:

“I would like to express my deepest gratitude to the entire team at North America Immigration Law Group (NAILG) for their outstanding support and expert guidance throughout my EB2-NIW petition process. NAILG far exceeded my expectations in every regard.

From our first interaction, the team was highly organized, communicative, and deeply knowledgeable. They took the time to carefully assess my academic and research profile and provided a realistic and transparent evaluation of my case.

What I especially appreciated was how effectively NAILG translated complex scientific findings into accessible, persuasive language suitable for USCIS officers. Their legal writing was sharp, evidence-based, and strategic. The process from document collection to final petition submission was smooth, well-structured, and always on schedule.

I wholeheartedly recommend NAILG to any researcher or professional navigating the EB2-NIW process. Their team combines legal precision with a genuine commitment to their clients’ success. Choosing them was one of the best decisions I made in my immigration journey, and I am sincerely thankful for their support.”

On June 7^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Biotechnology (Approval Notice).

General Field: Biotechnology

Position at the Time of Case Filing: Postdoctoral Associate

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: June 7^th, 2025

Processing Time: 1 month (Premium Processing Requested)

Case Summary:

NAILG (North America Immigration Law Group) is proud to announce the successful approval of an I-140 EB2-NIW (National Interest Waiver) petition for a postdoctoral associate from India specializing in biotechnology. When the client approached us seeking expert assistance with his petition, we conducted a thorough evaluation of his academic background and research accomplishments and recognized a strong case with excellent potential for success. We created a comprehensive petition underscoring the candidate’s significant accomplishments and supporting documentation. The petition was approved swiftly through the direct premium processing in just 1 month.

Proposed endeavor that aims to advance biotechnology and public health.

The client’s proposed endeavor centers on developing and applying advanced immunological and virological methodologies to investigate viral persistence and immune response mechanisms. By focusing on chronic diseases such as HIV and Epstein-Barr Virus (EBV), this research aims to advance therapeutic strategies and vaccine development. Client’s work has the potential to lower disease burdens significantly and improve public health outcomes in the United States, addressing critical healthcare challenges and contributing to national priorities in biotechnology and infectious disease control.

Demonstrating notable academic and professional milestones.

The client has published 8 peer-reviewed journal articles, including 5 as first author, along with 2 abstracts (1 of them first-authored) and 1 first-authored preprint in top journals, including no fewer than 3 highly ranked peer-reviewed journals. Notably, one of his articles ranks among the top 20% most cited papers in Molecular Biology & Genetics for its year of publication. Overall, his work has been cited 174 times, highlighting the significant impact and recognition of his research. Additionally, he has completed at least 12 peer reviews for respected journals, underscoring his role as a trusted expert and active contributor to the field.

Secured vital funding from prestigious institutions.

The client’s research has received funding from several prestigious organizations, highlighting the importance and impact of his work in biotechnology:

● National Institutes of Health (NIH)
● National Institute of Allergy and Infectious Diseases (NIAID)
● Department of Biotechnology, Government of India
● Moderna, Inc.

These institutions support research directed at advancing the national interest, including improving public health and developing innovative medical therapies.

Expert recommendations highlight the national importance of the research.

Two strong recommendation letters supported the petition, emphasizing the client’s significant contributions and their impact on public health and biotechnology in the United States. One leading expert remarked:

“The importance of [client’s] research is evidenced by his ingenuity in developing new techniques that have advanced our understanding of HIV reservoirs in children and thereby are informing new ways to achieve remission or cure. Ensuring that [client’s] work proceeds is thus not only important to the field but to the United States as well.”

Swift approval highlights the Strategic Petition.

NAILG’s strategic petition secured the client’s I-140 EB2-NIW approval in just 1 month via the premium processing, reflecting both his strong credentials and the vital impact of his work on U.S. health and biotechnology. We congratulate the client on this well-deserved achievement and look forward to his continued contributions.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.